A metabolic testing is used to measure the rate at which person’s body burns calories and uses oxygen during different activities or during rest or workouts. It is mostly used for weight loss purposes. It also measures how much lean mass such as organ tissue, brain, muscles, and many others is being used to fuel the body. During the metabolic testing procedure, a person breathes and reclines under a lightweight canopy hood for 20-30 minutes. It is one of the most valuable tool or technique that can help individuals make decisions about lifestyle habits that affect weight loss or weight gain. It is also used to screen organ functions and disease conditions such as diabetes, liver diseases, cardiovascular diseases, and kidney diseases.
The global metabolic testing market has been seeing ample growth from the past few years. The primary factors behind the growth of the market are ever-increasing healthcare infrastructure, growing technological advancements and rising prevalence rate of lifestyle diseases. Likewise, factors such as growing old age population, increasing awareness regarding health among people across the globe, rising incidence of obesity and heart related diseases are likely to improve growth of the market during the forecast period.
Nevertheless, factors such as high cost associated with equipment and software and reimbursement issues are some of the major restraining factors that could hamper the growth of the market.
The study analyses global metabolic testing market based on product, application, technology, end user, and geography.
Based on product, the market is bifurcated into CPET system, metabolic carts, body composition analyzers, ECGs/EKGs attachable to CPET systems and software. The CPET system is further segmented into portable systems and bench-top systems. CPET is a significant clinical tool used to assess exercise capacity and forecast result in patients with heart failure and other cardiac conditions. It is widely being used in a broad range of clinical applications for assessment of undiagnosed exercise intolerance and for objective determination of impairment and functional capacity.
Based on application, lifestyle diseases segment is projected to witness fast growth during the estimated timeframe. Rising prevalence rate of lifestyle diseases such as obesity, cardiovascular diseases, and type 2 diabetes and rising need to reduce this rate across the globe is accredited to the growth of the segment.
Based on technology, the market is segmented into VO2 max analysis, RMR analysis, and body composition analysis. These are most important tests for the metabolic testing. The VO2 max analysis or exercise test provides individuals information regarding the intensity levels at which their body uses oxygen and burns fat less or more efficiently. RMR analysis provides an estimate of the number of calories person burn when their body is at complete rest. And body composition analysis is a test or analysis method of describing what the body is made of, differentiating between minerals, protein, fat, and body water to give a snapshot of health.
Based on end user, hospital segment dominated the market in 2020 and is projected to maintain its dominance during the forecast period. Metabolic testing is widely used in expensive hospital or laboratory settings. However, many years ago, gyms and health clubs started providing metabolic assessments using more cost-efficient equipment. Thus increasing adoption of metabolic testing equipment and rising preference of the individuals towards hospital based metabolic testing are attributed to the growth of the market.
Geographically, the study is comprised of the key countries of North America, Europe, Asia-Pacific and Rest of the World. North America held the largest market share of global Metabolic Testing market and is likely to dominate the market over the estimated time frame. The US and Canada is likely to dominate the market during the forecast period. The presence of well-established healthcare industry across the region, supportive government initiatives, a surge the demand for quality medical care, and rise in patient and healthcare professional awareness levels, and rising incidences of metabolic diseases are some of the major factors that accredited to the growth of the market in the NA region.
The major key players of market includes AEI Technologies, Inc, Carefusion Corporation, Cortex Biophysik GMBH, Cosmed, General Electric Company, Geratherm Medical AG, Korr Medical Technologies, Inc, MGC Diagnostics Corporation, Microlife Medical Home Solutions, Inc, OSI Systems, Inc and Parvo Medics among others.
The study analyses global Metabolic Testing market based on product, application, technology, end user, and geography. Metabolic testing market by product is segmented into CPET systems, metabolic carts, body composition analyzers, ECGs/EKGs attachable to CPET systems, and software. The market finds application in critical care, dysmetabolic syndrome x, human performance testing, lifestyle diseases, metabolic disorders, and other applications. The lifestyle diseases segment is likely to dominate the market over the forecast period. Rising prevalence rate of lifestyle across the globe is attributed to the market growth. By technology, the market is segmented into VO2 max analysis, RMR analysis, and body composition analysis. By end user, the market is segmented into hospitals, laboratories, sports training centers, gyms, and other end users. The hospitals segment is likely to register fastest growth in years to come owing to the growing adoption of metabolic testing equipment in hospitals across the globe. Geographically, the study is comprised of the key countries of North America, Europe, Asia-Pacific and Rest of the World.
Why to buy this report: